Evidence map›Paper›PMID 28261209›Full record

ArticleFrontiers in immunology2017

GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic Cells.

Amairelys Belen Barroeta Seijas, Sonia Simonetti, Sara Vitale, Daniele Runci, Angela Caterina Quinci, Alessandra Soriani, Mattia Criscuoli, Irene Filippi, Antonella Naldini, Federico Maria Sacchetti and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Microbiota-derived HNature communications · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Amairelys Belen Barroeta SeijasInstitute of Molecular Biology and Pathology, National Research Council (CNR), c/o Department of Molecular Medicine, University of Rome "Sapienza", Rome, Italy; Department of Molecular Medicine, University of Rome "Sapienza", Rome, Italy.
Sonia SimonettiDepartment of Molecular Medicine, University of Rome "Sapienza" , Rome , Italy.
Sara VitaleInstitute of Molecular Biology and Pathology, National Research Council (CNR), c/o Department of Molecular Medicine, University of Rome "Sapienza" , Rome , Italy.
Daniele RunciIstituto Pasteur Italia - Fondazione Cenci Bolognetti , Rome , Italy.
Angela Caterina QuinciDepartment of Molecular Medicine, University of Rome "Sapienza" , Rome , Italy.
Alessandra SorianiDepartment of Molecular Medicine, University of Rome "Sapienza" , Rome , Italy.
Mattia CriscuoliDepartment of Molecular and Developmental Medicine, University of Siena , Siena , Italy.
Irene FilippiDepartment of Molecular and Developmental Medicine, University of Siena , Siena , Italy.
Antonella NaldiniDepartment of Molecular and Developmental Medicine, University of Siena , Siena , Italy.
Federico Maria SacchettiCentro Traumatologico Ortopedico Andrea Alesini Hospital , Rome , Italy.
Umberto TarantinoDepartment of Orthopaedics and Traumatology, University of Rome "Tor Vergata" , Rome , Italy.
Francesco OlivaDepartment of Orthopaedics and Traumatology, University of Rome "Tor Vergata" , Rome , Italy.
Eleonora PiccirilliDepartment of Orthopaedics and Traumatology, University of Rome "Tor Vergata" , Rome , Italy.
Angela SantoniDepartment of Molecular Medicine, University of Rome "Sapienza", Rome, Italy; Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Rome, Italy.
Francesca Di RosaInstitute of Molecular Biology and Pathology, National Research Council (CNR), c/o Department of Molecular Medicine, University of Rome "Sapienza" , Rome , Italy.
Sapienza University of Rome · ITUniversity of Rome Tor Vergata · ITUniversity of Siena · ITNational Research Council · ITCTO Andrea Alesini · ITIstituto Pasteur · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cell factor (SCF), the ligand of c-kit, is a key cytokine for hematopoiesis. Hematopoietic precursors express c-kit, whereas differentiated cells of hematopoietic lineage are negative for this receptor, with the exception of NK cells, mast cells, and a few others. While it has long been recognized that dendritic cells (DCs) can express c-kit, several questions remain concerning the SCF/c-kit axis in DCs. This is particularly relevant for DCs found in those organs wherein SCF is highly expressed, including the bone marrow (BM). We characterized c-kit expression by conventional DCs (cDCs) from BM and demonstrated a higher proportion of c-kit

Indexed as

bone marrowbone marrow-derived dendritic cellsconventional dendritic cell subsetsdendritic cell homeostasisdendritic cell survivalGM-CSFstem cell factor

Identifiers

PMID28261209
PMCPMC5311071
OpenAlexW2588188333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.